Time Release Niacin - 90 CT

Time Release Niacin by Ortho Molecular Products – Cardiovascular Support with Vitamin B3

Time Release Niacin by Ortho Molecular Products is a sustained-release niacin supplement designed to support cardiovascular health, healthy blood lipid levels, and balanced cholesterol metabolism. This practitioner-formulated vitamin B3 product uses a natural wax-matrix coating technology to release niacin gradually over six to eight hours, helping promote HDL support, lipid balance, and better tolerance with minimal flushing.

Key Time Release Niacin Benefits

• Supports healthy blood lipid levels already within the normal range
• Promotes healthy high-density lipoprotein levels
• Helps maintain healthy low-density lipoprotein levels and lipid particle size
• Supports healthy triglyceride levels
• Promotes endothelial function by increasing nitric oxide synthase activity

How Time Release Niacin Works

This sustained-release niacin formula delivers niacin slowly over a six- to eight-hour period to help reduce flushing while supporting healthy cholesterol balance. Niacin, also known as nicotinic acid, helps promote healthy lipoprotein metabolism, supports nitric oxide synthase activity, and assists the body in maintaining healthy circulation and cardiovascular function.

Key Functional Ingredients Include:

• Niacin (as Nicotinic Acid): Supports healthy HDL levels, healthy triglyceride balance, and normal lipid metabolism

Time Release Niacin is formulated with a proprietary natural wax-matrix coating technology to help deliver niacin gradually for improved tolerance. In a placebo-controlled study cited by the manufacturer, this specific form was associated with a low flushing rate.

Time Release Niacin Is Formulated For

• Individuals seeking practitioner-guided cholesterol support
• Those looking for targeted heart health supplement support
• Adults who want a well-tolerated time release niacin formula
• People seeking nutritional support for healthy triglycerides and HDL levels already within the normal range

Supplements support your health but do not replace a balanced diet. Always check with your healthcare practitioner if you have doubts about a new supplement. Or you may book a FREE product consultation with Holistic Health Partners. You may also want to explore our Cholesterol support products. 

Recommendation: 1 tablet three times per day with a meal or as recommended by your health care professional.

Serving Size: 1 Tablet
Servings Per Container: 90

Does not contain: Gluten, corn, yeast, artificial colors and flavors.

Warnings/Cautions: If you are pregnant or nursing, consult your physician before taking this product. This product is designed to release niacin over a six- to eight-hour period to minimize flushing (Avoiding hot beverages is recommended). A small percentage of people may still experience harmless flushing while taking this product.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

Click here to view Product Info Sheet

References:

1. Keenan JM, Fontaine PL et al. Niacin revisited. A randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia. Arch Intern Med. 1991 Jul;151(7):1424-32.
2. Keenan JM, Bae CY et al. Treatment of hypercholesterolemia: comparison of younger versus older patients using wax-matrix sustained-release niacin. J Am Geriatr Soc. 1992;40(1):12-8.
3. Bissett DL, Oblong JE, Berge CA, et al. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg. 2005;31:860-865.
4. Benavente CA, Jacobson MK, Jacobson EL. NAD in skin: therapeutic approaches for niacin. Curr Pharm Des. 2009;15(1):29-38.
5. Elam M, Hunninghake DB, Davis KB, et al. Effects of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: a randomized trial. Arterial Disease Multiple Intervention Trial. JAMA. 2000;284:1263-1270.
6. Canner PL, Furberg CD, Terrin ML, McGovern ME. Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the Coronary Drug Project). Am J Cardiol. 2005;95(2):254-7.
7. Guyton JR. Niacin in cardiovascular prevention: mechanisms, efficacy, and safety. Curr Opin Lipidol. 2007 Aug;18(4):415-20.
8. McKenney J. New perspectives on the use of niacin in the treatment of lipid disorders. Arch Intern Med. 2004 Apr 12;164(7):697-705.
9. Morgan JM, Carey CM, Lincoff A, Capuzzi DM. The effects of niacin on lipoprotein subclass distribution. Prev Cardiol. 2004;7(4):182-7.
10. AIM-HIGH Investigators. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol. Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH). Am Heart J. 2011 Mar;161(3):471-477.e2.
11. Kannel WB. Recent findings from the Framingham study—I. Med Times. 1978 Apr;106(4):23-27.
12. Hulley SB. The US National Cholesterol Education Program. Adult treatment guidelines. Drugs. 1988;36 Suppl 3:100-04.